💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
User | Tweets |
---|---|
@Allstocknews | 3 |
![]() |
@Allstocknews $BIOD New Form PRE 14A for Albireo Pharma Inc From our Stock News Alerts App April 16th 2021, 8:04pm |
![]() |
@Allstocknews $BIOD Albireo Expands Leadership with Joan Connolly as Chief Technology Officer From our Stock News Alerts App April 13th 2021, 12:04pm |
![]() |
@Allstocknews $BIOD Albireo to Participate in the Needham 20th Annual Virtual Healthcare Conference From our Stock News Alerts App April 6th 2021, 12:04pm |
![]() |
@FlashAlert_me $BIOD [15s. delayed] filed SEC form 4: Chief Commercial Officer Stephenson Pamela: Disposed 422 of Common Stock at… https://t.co/74buDNCUn7 March 31st 2021, 11:03pm |
![]() |
@Allstocknews $BIOD Albireo Announces First Patients Dosed in Two New Studies From our Stock News Alerts App March 25th 2021, 12:03pm |
![]() |
@Allstocknews $BIOD Albireo Spotlights Global Patient Communities on Rare Disease Day From our Stock News Alerts App February 26th 2021, 1:02pm |
![]() |
@Allstocknews $BIOD New Form S-3ASR for Albireo Pharma Inc From our Stock News Alerts App February 25th 2021, 9:02pm |
![]() |
@Allstocknews $BIOD New Form S-8 for Albireo Pharma Inc From our Stock News Alerts App February 25th 2021, 9:02pm |
![]() |
@FlashAlert_me $BIOD [15s. delayed] filed form S-3ASR on February 25, 16:16:03 https://t.co/UaA88Be96k February 25th 2021, 9:02pm |
![]() |
@Allstocknews $BIOD New Form 10-K for Albireo Pharma Inc From our Stock News Alerts App February 25th 2021, 1:02pm |
![]() |
@Allstocknews $BIOD Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update From our Stock News Alerts App February 25th 2021, 1:02pm |
![]() |
@Allstocknews $BIOD Albireo to Participate in Cowen and H.C. Wainwright Global Investor Conferences From our Stock News Alerts App February 23rd 2021, 1:02pm |
![]() |
@Allstocknews $BIOD Albireo to Report Q4 and Year-End 2020 Financial Results on February 25 From our Stock News Alerts App February 18th 2021, 1:02pm |
![]() |
@FlashAlert_me $BIOD [15s. delayed] filed form SC 13G/A on February 16, 15:36:06 https://t.co/Y40CB0ZVid February 16th 2021, 8:02pm |
![]() |
@Allstocknews $BIOD New Form SC 13G/A for Albireo Pharma Inc From our Stock News Alerts App February 12th 2021, 12:02pm |
![]() |
@FlashAlert_me $BIOD [15s. delayed] filed form SC 13G/A on February 12, 07:01:51 https://t.co/Rzr70ZD08n February 12th 2021, 12:02pm |
![]() |
@PaulTorresCohen Paul Torres-Cohen $BIOD February 12th 2021, 2:02am |
![]() |
@Allstocknews $BIOD New Form 8-K for Albireo Pharma Inc From our Stock News Alerts App February 11th 2021, 6:02pm |
![]() |
@FlashAlert_me $BIOD [15s. delayed] filed form 8-K on February 11, 13:30:30: Item2.02: Results of Operations & Financial Condition https://t.co/tYsHFsTJyc February 11th 2021, 6:02pm |
![]() |
@Allstocknews $BIOD Albireo Presents Odevixibat Commercialization Road to $1 Billion From our Stock News Alerts App February 11th 2021, 1:02pm |
![]() |
@Allstocknews $BIOD New Form SC 13G for Albireo Pharma Inc From our Stock News Alerts App February 2nd 2021, 8:02pm |
![]() |
@Allstocknews $BIOD New Form 4 for Albireo Pharma Inc From our Stock News Alerts App January 25th 2021, 10:01pm |
![]() |
@Allstocknews $BIOD New Form 4/A for Albireo Pharma Inc From our Stock News Alerts App January 25th 2021, 10:01pm |
![]() |
@FlashAlert_me $BIOD [15s. delayed] filed form 8-K on January 25, 08:11:54: Item8.01: Other Material Events https://t.co/AvGmNwqCkb January 25th 2021, 1:01pm |
![]() |
@Allstocknews $BIOD Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat From our Stock News Alerts App January 25th 2021, 1:01pm |
![]() |
@Allstocknews $BIOD Albireo Recognizes International Alagille Syndrome Awareness Day 2021 From our Stock News Alerts App January 22nd 2021, 1:01pm |
![]() |
@Allstocknews $BIOD Stock Quote Notification for Albireo Pharma Inc From our Stock News Alerts App January 20th 2021, 11:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.